2Marcassa C, Bax JJ, Bengel F, et al. Clinical value, cost-effectiveness, and safety of myocardial perfusion scintigraphy: a position statement. J Eur Heart, 2008, 29:557-563.
4Dilsizian V, Bateman TM, Bergmann SR, et al. Metabolic imaging with beta-methyl-p-[ ( 123 ) I ]-iodophenyl-pentadecanoic acid identifies ischemic memory after demand ischemia. Circulation, 2005,112:2169-2174.
5Kawai Y, Tsukamoto E, Nozaki Y, et al. Significance of reduced uptake of iodinated fatty acid analogue for the evaluation of patients with acute chest pain. J Am Coll Cardiol, 2001,38:1888- 1894.
7Jacobson AF, Lombard J, Banerjee G, et al. ^123I-MIBG scintigraphy to predict risk for adverse cardiac outcomes in heart failure patients: design of two prospective muhieenter international trials. J Nucl Cardiol,2009, 16:113-121.
8Matsunari I, Schricke U, Bengel FM, et al. Extent of cardiac sympathetic neuronal damage is determined by the area of ischemia in patients with acute coronary syndromes. Circulation, 2000, 101:2579-2585.
9Travin MI. A potential key role for radionuclide imaging in the prediction and prevention of sudden arrhythmic cardiac death. J Nucl Med,2008, 49 : 173-175.
